• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺增生症的自然病史:社区男性排尿症状的纵向变化

Natural history of prostatism: longitudinal changes in voiding symptoms in community dwelling men.

作者信息

Jacobsen S J, Girman C J, Guess H A, Rhodes T, Oesterling J E, Lieber M M

机构信息

Department of Health Sciences Research (Section of Clinical Epidemiology), Mayo Clinic, Rochester, Minnesota 55905, USA.

出版信息

J Urol. 1996 Feb;155(2):595-600. doi: 10.1016/s0022-5347(01)66461-9.

DOI:10.1016/s0022-5347(01)66461-9
PMID:8558668
Abstract

PURPOSE

We report the results of 3 contacts during 42 months of The Olmsted County Study of Urinary Symptoms and Health Status Among Men, a longitudinal cohort study of men 40 to 79 years old that was initiated in 1990 to describe changes in lower urinary tract symptom severity.

MATERIALS AND METHODS

At baseline and followup, men completed questionnaires that elicited urinary symptom severity with questions nearly identical to those of the American Urological Association symptom index:

RESULTS

Overall, there was an average increase in American Urological Association symptom index of approximately 0.18 (95% confidence interval 0.13 to 0.24) points per year of followup. The average annual symptom score slope and variability in slope increased with patient age at baseline from a mean of 0.05 +/- 1.06 (standard deviation) per year among men in the forties to 0.44 +/- 1.35 per year for men in the sixties, and decreased to 0.14 +/- 1.42 per year for men in the seventies. The age-related changes in symptom severity mirror previous estimates of prostatic growth from autopsy prevalence studies.

CONCLUSIONS

These results demonstrate a slow but measurable progression in urinary symptom severity among community dwelling men for 42 months of followup.

摘要

目的

我们报告了在奥尔姆斯特德县男性泌尿系统症状与健康状况研究的42个月期间3次随访的结果,该研究是一项针对40至79岁男性的纵向队列研究,始于1990年,旨在描述下尿路症状严重程度的变化。

材料与方法

在基线和随访时,男性完成了问卷调查,这些问卷通过与美国泌尿外科学会症状指数中几乎相同的问题来引出泌尿系统症状严重程度。

结果

总体而言,随访期间美国泌尿外科学会症状指数平均每年增加约0.18分(95%置信区间为0.13至0.24)。平均每年症状评分斜率以及斜率的变异性随着基线时患者年龄的增加而增加,从四十多岁男性的平均每年0.05±1.06(标准差)增加到六十多岁男性的平均每年0.44±1.35,七十多岁男性则降至平均每年0.14±1.42。症状严重程度与年龄相关的变化反映了之前尸检患病率研究对前列腺生长的估计。

结论

这些结果表明,在为期42个月的随访中,社区居住男性的泌尿系统症状严重程度呈缓慢但可测量的进展。

相似文献

1
Natural history of prostatism: longitudinal changes in voiding symptoms in community dwelling men.前列腺增生症的自然病史:社区男性排尿症状的纵向变化
J Urol. 1996 Feb;155(2):595-600. doi: 10.1016/s0022-5347(01)66461-9.
2
Prostatic central zone volume, lower urinary tract symptom severity and peak urinary flow rates in community dwelling men.社区居住男性的前列腺中央区体积、下尿路症状严重程度及最大尿流率
J Urol. 1999 Mar;161(3):831-4.
3
Concomitant longitudinal changes in frequency of and bother from lower urinary tract symptoms in community dwelling men.社区男性下尿路症状的频率和困扰的伴随纵向变化。
J Urol. 2002 Oct;168(4 Pt 1):1446-52. doi: 10.1016/S0022-5347(05)64471-0.
4
Natural history of prostatism: impaired health states in men with lower urinary tract symptoms.前列腺增生症的自然病史:下尿路症状男性的健康状态受损
J Urol. 1997 May;157(5):1711-7. doi: 10.1016/s0022-5347(01)64842-0.
5
Natural history of prostatism: risk factors for acute urinary retention.前列腺增生症的自然病史:急性尿潴留的危险因素。
J Urol. 1997 Aug;158(2):481-7. doi: 10.1016/s0022-5347(01)64508-7.
6
Treatment for benign prostatic hyperplasia among community dwelling men: the Olmsted County study of urinary symptoms and health status.社区居住男性良性前列腺增生的治疗:奥姆斯特德县泌尿系统症状与健康状况研究
J Urol. 1999 Oct;162(4):1301-6.
7
Natural history of prostatism: high American Urological Association Symptom scores among community-dwelling men and women with urinary incontinence.前列腺增生症的自然病史:社区居住的尿失禁男性和女性中美国泌尿外科学会症状评分较高
Urology. 1998 Feb;51(2):213-9. doi: 10.1016/s0090-4295(97)00505-0.
8
Association between family history of benign prostatic hyperplasia and urinary symptoms: results of a population-based study.
Am J Epidemiol. 1995 Nov 1;142(9):965-73. doi: 10.1093/oxfordjournals.aje.a117745.
9
Natural history of prostatism: worry and embarrassment from urinary symptoms and health care-seeking behavior.
Urology. 1994 May;43(5):621-8. doi: 10.1016/0090-4295(94)90174-0.
10
Longitudinal changes in peak urinary flow rates in a community based cohort.基于社区队列的最大尿流率的纵向变化。
J Urol. 2000 Jan;163(1):107-13.

引用本文的文献

1
Urodynamics tests for the diagnosis and management of male bladder outlet obstruction: long-term follow-up of the UPSTREAM non-inferiority RCT.用于男性膀胱出口梗阻诊断和管理的尿动力学检查:UPSTREAM非劣效性随机对照试验的长期随访
Health Technol Assess. 2025 Jul;29(26):1-57. doi: 10.3310/SLPT4675.
2
Lc-ms-based untargeted metabolomics reveals potential mechanisms of histologic chronic inflammation promoting prostate hyperplasia.基于液相色谱-质谱联用的非靶向代谢组学揭示了组织学慢性炎症促进前列腺增生的潜在机制。
PLoS One. 2024 Dec 23;19(12):e0314599. doi: 10.1371/journal.pone.0314599. eCollection 2024.
3
Cost-utility of minimally invasive therapies vs. pharmacotherapy as initial therapy for benign prostatic hyperplasia A Canadian healthcare payer perspective.
微创治疗与药物治疗作为良性前列腺增生初始治疗的成本效益:加拿大医疗保健支付方视角
Can Urol Assoc J. 2023 Apr;17(4):103-110. doi: 10.5489/cuaj.8045.
4
Correlation Between Prostate Volume Measured by Ultrasound and Detrusor Wall Thickness in Men with Benign Prostatic Hypertrophy.良性前列腺增生男性患者超声测量的前列腺体积与逼尿肌壁厚度之间的相关性
J West Afr Coll Surg. 2020 Oct-Dec;10(4):1-5. doi: 10.4103/jwas.jwas_19_22. Epub 2022 Jun 8.
5
Pharmacotherapy vs. minimally invasive therapies as initial therapy for moderate-to-severe benign prostatic hyperplasia: a cost-effectiveness study.药物治疗与微创治疗作为中重度良性前列腺增生初始治疗方法的成本效益研究
Prostate Cancer Prostatic Dis. 2023 Mar;26(1):113-118. doi: 10.1038/s41391-022-00561-2. Epub 2022 Jun 10.
6
Fexapotide triflutate vs oral pharmacotherapy as initial therapy for moderate-to-severe benign prostate hyperplasia patients: a cost-effectiveness analysis.三氟拉肽与口服药物治疗中度至重度良性前列腺增生患者的初始治疗:成本效益分析。
BMC Urol. 2022 May 13;22(1):76. doi: 10.1186/s12894-022-01025-4.
7
BPH nomogram using IPSS, prostate volume, peak flow rate, PSA and median lobe protrusion for predicting the need for intervention: development and internal validation.使用国际前列腺症状评分(IPSS)、前列腺体积、最大尿流率、前列腺特异性抗原(PSA)和中叶突出度预测干预需求的良性前列腺增生列线图:开发与内部验证
Am J Clin Exp Urol. 2021 Jun 15;9(3):202-210. eCollection 2021.
8
Prostatic Artery Embolization for Benign Prostatic Hyperplasia: A Health Technology Assessment.前列腺动脉栓塞术治疗良性前列腺增生症:一项卫生技术评估。
Ont Health Technol Assess Ser. 2021 Jun 4;21(6):1-139. eCollection 2021.
9
Urodynamics tests for the diagnosis and management of bladder outlet obstruction in men: the UPSTREAM non-inferiority RCT.尿动力学检查在男性膀胱出口梗阻诊断和治疗中的应用:UPSTREAM 非劣效 RCT 研究。
Health Technol Assess. 2020 Sep;24(42):1-122. doi: 10.3310/hta24420.
10
Complications after surgery for benign prostatic enlargement: a population-based cohort study in Ontario, Canada.良性前列腺增生症手术后的并发症:加拿大安大略省的一项基于人群的队列研究。
BMJ Open. 2019 Dec 30;9(12):e032170. doi: 10.1136/bmjopen-2019-032170.